This inventor holds 13 USPTO granted patents and 2 published patent applications. Top assignees: Pernix Ireland Pain Limited, Pemix Ireland Pain Limited, Persion Pharmaceuticals LLC. Active years: 2016-2020.
Location History:
- Williamsville, NY (US) (2016 - 2019)
- Willamsville, NY (US) (2020)
Company Filing History:
5 out of 5 
3 out of 3 
3 out of 3 Years Active: 2016-2020
Title: The Innovative Contributions of Christopher M. Rubino
Introduction
Christopher M. Rubino, an accomplished inventor based in Williamsville, NY, has made significant strides in the pharmaceutical industry through his innovative work. Holding 13 patents, Rubino has focused on developing compositions and methods that improve patient care, particularly for those with specific medical needs.
Latest Patents
One of Rubino's most recent patents revolves around treating pain in patients with hepatic impairment. His invention is an extended-release composition for an analgesic active pharmaceutical ingredient, specifically hydrocodone. This composition is designed to be delivered in oral dosage forms such as gelatin capsules, featuring a release mechanism that minimizes the clinical significance of increased hydrocodone exposure in patients with hepatic impairment. Additionally, the packaging includes a kit with a primary package and insert, designed without specific warnings or dosing instructions for those with mild or moderate hepatic impairment, thereby indicating that dosage adjustments are unnecessary for these patients.
Career Highlights
Throughout his career, Rubino has been affiliated with notable companies such as Pernix Ireland Pain Limited. His work in these organizations has advanced the development of pain management solutions, addressing both efficacy and safety in treatments for patients with unique medical conditions.
Collaborations
In his professional journey, Rubino has collaborated with esteemed colleagues like Andrew Hartman and Cynthia Y. Robinson. These partnerships have been integral in driving forward innovative projects and reinforcing the commitment to enhancing patient care through scientific advancements.
Conclusion
Christopher M. Rubino's pioneering efforts and dedication to innovation in the pharmaceutical field are noteworthy. His patents, particularly focused on improving the treatment of pain in vulnerable patient populations, exemplify the impact that a dedicated inventor can have on healthcare and the lives of patients. Through his work, Rubino continues to inspire future innovation in pain management and pharmacology.